Seggewiss H, Gleichmann U, Fassbender D, Vogt J, Mannebach H, Minami K
Department of Cardiology, Heart Center North Rhine-Westphalia, University Hospital of the Ruhr University of Bochum, Bad Oeynhausen, Germany.
Eur Heart J. 1992 Dec;13(12):1649-57. doi: 10.1093/oxfordjournals.eurheartj.a060120.
Prolonged dilatation with an autoperfusion balloon catheter (APBC) (High-Flow-CPC-Mainz (Schneider) in 23 cases and Stack Perfusion (ACS) in 50 cases) was carried out in 73 patients (60 men, 13 women, mean age 59.3 +/- 8.8 years) with acute vascular complications occurring during PTCA (25 occlusive dissections (34%), five thrombotic occlusions (7%), 42 non-occlusive dissections (58%) and one non-occlusive thrombus with reduction of flow (1%)) in order to avoid stent implantation or emergency bypass surgery. On average 1.5 +/- 0.8 inflations were carried out per patient with a mean maximum inflation time of 14.1 +/- 8.4 min and a mean total inflation time of 16.8 +/- 12.3 min. In 61 patients (83.5%), the vascular complication could be controlled successfully with APBC, but in 12 APBC was not successful. Eight patients (11%) had emergency surgery. A stent was implanted in three patients (4.1%), and one suffered an acute myocardial infarction. Out of the 61 patients with positive result after prolonged dilatation, the hospital phase was uncomplicated in 53 (86.9%), five (8.2%) suffered an infarct with a maximum rise in CK of 350 U.l-1, two with multivessel disease had elective operations and one was dilated a second time because of a subacute reocclusion. Our experience indicates that when an acute vascular complication occurs, prolonged dilatation with an APBC is good interventional therapy avoiding stent implantation or emergency bypass surgery. However, new techniques cannot always replace surgery so an emergency bypass operation may still be necessary.
对73例(60例男性,13例女性,平均年龄59.3±8.8岁)在经皮冠状动脉腔内血管成形术(PTCA)期间发生急性血管并发症的患者(25例闭塞性夹层(34%)、5例血栓性闭塞(7%)、42例非闭塞性夹层(58%)和1例伴有血流减少的非闭塞性血栓(1%))使用自动灌注球囊导管(APBC)(23例使用高流量CPC-美因茨导管(施耐德公司),50例使用堆叠灌注导管(ACS公司))进行长时间扩张,以避免植入支架或进行急诊搭桥手术。每位患者平均进行1.5±0.8次充盈,平均最大充盈时间为14.1±8.4分钟,平均总充盈时间为16.8±12.3分钟。61例患者(83.5%)的血管并发症可通过APBC成功控制,但12例患者使用APBC未成功。8例患者(11%)接受了急诊手术。3例患者(4.1%)植入了支架,1例发生急性心肌梗死。在长时间扩张后结果为阳性的61例患者中,53例(86.9%)住院期间无并发症,5例(8.2%)发生梗死,肌酸激酶(CK)最高升高350 U.l-1,2例患有多支血管病变的患者接受了择期手术,1例因亚急性再闭塞而再次扩张。我们的经验表明,当发生急性血管并发症时,使用APBC进行长时间扩张是一种很好的介入治疗方法,可避免植入支架或进行急诊搭桥手术。然而,新技术并不总能取代手术,因此急诊搭桥手术可能仍然必要。